Is fibromyalgia a neurological disease?;¿Es la fibromialgia una enfermedad neurológica?

Neurologia

Volumn 23, Issue 9, 2008, Pages 593-601

  Arias Gómez, Manuel ^a,b  

^a HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^b NONE   (Spain)

Author keywords

Chronic pain; Fibromyalgia; Nociceptive system

Indexed keywords

ARTICLE; CHRONIC PAIN; CHRONIC STRESS; CLINICAL FEATURE; EMOTIONAL DISORDER; FATIGUE; FIBROMYALGIA; HEADACHE; PATHOGENESIS; PSYCHOSOMATIC DISORDER; SLEEP DISORDER;

EID: 56849115618     PISSN: 02134853     EISSN: 15781968     Source Type: Journal    
DOI: None     Document Type: Article

References (84)

1. International Association for Study of Pain. The subcommittee on taxonomy. Classification of chronic pain. Description of chronic pain syndromes and definitions of pain terms. Pain Suppl 1986;3:S1-226.
2. Craig AD. A new view of pain as a homeostatic emotion. Trends Neurosci 2003;26:303-7.
3. Price DD. Psychological and neural mechanisms of the affective dimension of pain. Science 2000;288:1769-72.
4. Helmes E, Goburdhun A. Cognitions related to chronic pain: revision and extension of the cognitive evaluation questionnaire. Clin J Pain 2007;23:53-61.
5. Wolfe F. The clinical syndrome of fibrositis. Am J Med 1986;81:7-14.
6. Simms RW. Fibromyalgia is not a muscle disorder. Am J Med Sci 1998;315:346-50.
7. Mease P. Fibromyalgia syndrome: review of clinical presentation, pathogenesis, outcome measures, and treatment. J Rheumatol 2005;32(Suppl. 75):6-21.
8. Bennet RM. Emerging concepts in the neurobiology of chronic pain: evidence of abnormal sensory processing in fibromyalgia. Mayo Clin Proc 1999;74:385-98.
9. Edwards RR. Individual differences in endogenous pain modulation as a risk factor for chronic pain. Neurology 2005;65:437-43.
10. Pillemer SR, Bradley LA, Crofford LJ, Moldofsky H, Chrousos GP. The neuroscienee and endocrinology of fibromyalgia. Arthritis Rheum 1997;40:1928-39.
11. Bradley LA, McKendree-Smith NL, Alarcon GS, Cianfrini LR. Is fibromyalgia a neurologic disease? Curr Pain Headache Rep 2002;6:106-14.
12. Portenoy RK. Mechanism of clinical pain. Observations and speculations. Neurol Clin 1989;7:205-30.
13. Serra J. Tratado de dolor neuropático. Madrid: Editorial Panamericana, 2006.
14. Staud R, Vierck CJ, Cannon RL, Mauderli AP, Price DD. Abnormal sensitization and temporal summation of second pain (wind up) in patients with fibromyalgia syndrome. Pain 2001;91:165-75.
15. Bennet CJ. Update in the neurophysiology of pain transmission and modulation: focus on the NMDA-receptor. J Pain Symptom Manage 2000;19:S2-S6.
16. Meeus M, Nijs J. Central sensitization: a biopsychosocial explanation for chronic widespread pain in patients with fibormyalgia and chronic fatigue syndrome. Clin Rheumatol 2007;26:465-73.
17. Staud R, Price DD, Robinson MF, Mauderli AP, Vierck CJ. Maintenance of windup of second pain requires less frequent stimulation in fibromyalgia patients compared to normal controls. Pain 2004;110:689-96.
18. Melzack R, Wall PD. Pain mechanisms: a new theory. Science 1965;150:971-9.
19. Melzack R. Evolution of the neuromatrix theory of pain. The Prithvi Raj lecture: presented at the Third Word Congress of World Institute of Pain, Barcelona 2004 Pain Practice 2005;5:85-94.
20. Melzack R. Pain: an overview. Acta Anaesthesiol Scand 1999;43:880-4.
21. Melzack R. From the gate to the neuromatrix. Pain 1999;82 (Suppl. 6):S121-6.
22. Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C, Goldenberg DL, et al. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Arthritis Rheum 1990;33:160-72.
23. Gowers WR. Lumbago: its lessons and analogues. BMJ 1904;1:117-21.
24. Smythe HA, Moldosfky H. Two contributions to understanding the «fibrositis» syndrome. Bull Rheum Dis 1978;10:95-103.
25. Wolfe F, Hawley DJ. Evidence of disordered symptom appraisal in fibromyalgia: increased rates of reported comorbidity and comorbidity severity. Clin Exp Rheumatol 1999;17:297-303.
26. Buskila D, Odes LR, Neumann L, Odes HS. Fibromyalgia in inflammatory bowel disease. J Rheumatol 1999;26:1167-71.
27. Hedenberg-Magnusson B, Ernberg M, Kopp S. Presence of orofacial pain and temporomandibular disorder in fibromyalgia. A study by questionnaire. Swed Dent J 1999;23:185-92.
28. ter Borg EJ, Gerards-Rociu E, Haanen HC, Westers P. High frequency of hysterectomies and appendectomies in fibromyalgia compared with rheumatoid arthritis: a pilot study. Clin Rheumatol 1999;18:1-3.
29. Ifergane G, Buskila D, Simiseshvely N, Zeev K, Cohen H. Prevalence of fibromyalgia syndrome in migraine patients. Cephalgia 2006;26:451-6.
30. Hudson JI, Goldenberg DL, Pope HG, Keck PE, Schlesinger L. Comorbidity of fibromyalgia with medical and psychiatric disorders. Am J Med 1992;92:363-7.
31. Cohen H, Neumann L, Haiman Y, Matar MA, Press J, Buskila D. Prevalence of post traumatic stress disorder in fibromyalgia patients: overlapping syndromes or post traumatic fibromyalgia syndrome? Semin Arthritis Rheum 2002;32:38-50.
32. Arias M. Trastornos psicógenos. Concepto, terminología y clasificación. Neurología 2004;19:387-5.
33. Clauw DJ. Elusive syndromes: treating the biologic basis of fibromyalgia and related syndromes. Cleve Clin J Med 2001;68:832-4.
34. Matínez-Sánchez F, Ato-García M, Ortiz-Soria B. Alexithymia: state or trait? Span J Psicol 2003;6:51-9.
35. Kirsch A, Bernardy K. Fibromyalgia, facial expression and emotional experience. Psychopathology 2007;40:203-8.
36. Brosschot JF, Aarsse HR. Restricted emotional processing and somatic attribution in fibromyalgia. Int J Pchyatry Med 2001;31:127-46.
37. Golberg YP, MacFarlane J, MacDonald ML, Thompson J, Dube MP, Mattice M, et al. Loss-of-function mutations in the Nav1.7 gene underlie congenital indifference to pain in multiple human populations. Clin Genet 2007;71:311-9.
38. Aaron LA, Burke MM, Buchwald D. Overlapping conditions among patients with chronic fatigue syndrome, fibromyalgia, and temporomandibular disorder. Arch Intern Med 2000;160:221-7.
39. Sharpe MK, Archard LC, Banatvala JE, Borysiewicz LK, Clare AW, David A, et al. A report-chronic fatigue syndrome: guidelines for research. J R Soc Med 1991;84:118-21.
40. Jason LA, Taylor RR, Kennedy CL. Chronic fatigue syndrome, fibromyalgia, and multiple chemical sensitivities in a community-based sample of persons with chronic fatigue syndrome-like symptoms. Psyehosom Med 2000;62:655-63.
41. Buchwald D, Garrity D. Comparison of patients with chronic fatigue syndrome, fibromyalgia, and chemical sensitivities. Arch Intern Med 1994;154:2049-53.
42. Wysenbeek AJ, Shapira Y, Leibovici L. Primary fibromyalgia and the chronic fatigue syndrome. Rheumatol Int 1991;10:227-9.
43. Papageorgiou AC, Silman AJ, Macfarlane GJ. Chronic widespread pain in the population: a seven years follow up study. Ann Rheym Dis 2002;61:1071-4.
44. Mehendale AW, Goldman MP. Fibromyalgia syndrome, idiopathic widespread persistent pain or syndrome of mialgic encephalomyelopathy (SME): what is its nature. Pain Practice 2002;2:35-46.
45. Ribera J, Alegre C, Ballina FJ, Carbonel J, Carmona L, Castel B, et al. Documente de eonsenso de la Sociedad Española de Reumatología sobre la fibromialgia. Reumatol Clin 2006;2(Suppl. 1): S55-66.
46. Sociedad Española de Reumatología. Estudio EPISER. Prevalcncia e impacto de las enfermedades reumáticas en la población adulta española. Madrid: Sociedad Española de Reumatología, 2001.
47. White KP, Speechley M, Harth M, Ostbye T. The London Fibromyalgia Epidemiology Study: comparing the demographic and clinical characteristics in 100 random community cases of fibromyalgia versus controls. J Rheumatol 1999;26:1577-85.
48. Wolfe F, Ross K, Anderson J, Russell IJ, Hebert L. The prevalence and characteristics of fibromyalgia in the general population. Arthritis Rheum 1995;38:19-28.
49. Makela M, Heliovaara M. Prevalence of primary fibromyalgia in the Finnish population. Br Med J 1991;303:216-9.
50. Fitzcharles MA, Esdaile JM. The overdiagnosis of fibromyalgia syndrome. Am J Med 1997;103:44-50.
51. Wolfe F, Anderson J, Harkness D, Bennett RM, Caro XJ, Goldenberg DL, et al. A prospective, longitudinal, multieenter study of service utilization and costs in fibromyalgia. Arthritis Rheum 1997;40:1560-70.
52. Henriksson C, Liedberg G. Factors of importance for work disability in women with fibromyalgia. J Rheumatol 2000;27:1271-6.
53. White KP, Speechley M, Harth M, Ostbye T. Comparing self-reported function and work disability in 100 community cases of fibromyalgia syndrome versus controls in London, Ontario: the London Fibromyalgia Epidemiology Study. Arthritis Rheum 1999;42:76-83.
54. Bombardier CH, Buchwald D. Chronic fatigue, chronic fatigue syndrome, and fibromyalgia: disability and health-care use. Med Care 1996;34:924-30.
55. Assefi NP, Coy TV, Uslan D, Smith WR, Buchwald D. Financial, occupational, and personal consequences of disability in patients with chronic fatigue syndrome and fibromyalgia compared to other fatiguing conditions. J Rheumatol 2003;30:804-8.
56. Schaefer KM. Sleep disturbances and fatigue in woman with fibromyalgia and chronic fatigue syndrome. J Obstet Gynecol Neonatal Nurs 1995;24:229-33.
57. Roizenblatt S, Moldosky H, Benedito-Silva AA, Tufik S. Alpha sleep characteristics in fibromyalgia. A controlled study. Arthritis Rheum 2001;44:222-30.
58. Larson AA, Giovengo SL, Russell IJ, Michalek JE. Changes in the concentrations of amino acids in the cerebrospinal fluid that correlate with pain in patients with fibromyalgia: implications for nitric oxide pathways. Pain 2000;87:201-11.
59. Evengard B, Nilsson CG, Lindh G, Lindquist L, Eneroth P, Fredrikson S, et al. Chronic fatigue syndrome differs from fibromyalgia: no evidence for elevated substance P levels in cerebrospinal fluid of patients with chronic fatigue syndrome. Pain 1998;78:153-5.
60. Watkins LR, Maier SF. The pain of being sick: implications of immune-to-brain communication for understanding pain. Ann Rev Psychol 2000;51:29-57.
61. Werle E, Fisher H, Muller A, Fiehn W, Eich W. Antibodies against serotonin have no diagnostic relevance in patients with fibromyalgia syndrome. J Rheumatol 2001;28:595-600.
62. Crofford LJ, Pillemer SR, Kalogeras KT, Cash JM, Miehelson D, Kling MA, et al. Hypothalamic-pituitary-adrenal axis perturbations in patients with fibromyalgia. Arthritis Rheum 1994;37:1583-92.
63. Adler GK, Manfredsdottir VF, Creskoff KW. Neuroendocrine abnormalities in fibromyalgia. Curr Pain Headache Rep 2002;6:289-98.
64. Mountz JM, Bradley LA, Alarcon GS. Abnormal functional activity of the central nervous system in fibromyalgia syndrome. Am J Med Sci 1998;315:385-96.
65. Simms RW, Roy SH, Hrovat M, Anderson JJ, Skrinar G, LePoole SR, et al. Lack of association between fibromyalgia syndrome and abnormalities in muscle energy metabolism. Arthritis Rheum 1994;37:794-800.
66. Epstein SA, Kay G, Clauw D, Heaton R, Klein D, Krupp L, et al. Psychiatric disorders in patients with fibromyalgia. A multicenter investigation. Psychosomatics 1999;40:57-63.
67. Buskila D, Sarzi-Puttini P. Biology and therapy of fibromyalgia. Genetics aspects of fibromyalgia syndrome. Arthritis Res Ther 2006;8:218-22.
68. Gursoy S, Erdal E, Herken H, Madenci E, Alasehirli B, Erdal N. Significance of catechol-O-methyltransferase gene polymorphism in fibromyalgia syndrome. Rheumatol Int 2003;23:104-7.
69. Krupp LB, La Rocca NG, Muir-Nash J, Steinberg AD. The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol 1989;46:1121-3.
70. Burckhardt CS, Clark SR, Bennett RM. The Fibromyalgia Impact Questionnaire: development and validation. J Rheumatol 1991;18:728-33.
71. Dunkl PR, Taylor AG, McConnell GG, Alfano AP, Conaway MR. Responsiveness of fibromyalgia clinical trial outcome measures. J Rheumatol 2000; 27:2683-91.
72. Peres MFP, Young WB, Kaup AO, Zukerman E, Silberstein SD. Fibromyalgia is common in patients with transformed migraine. Neurology 2001;57:1326-8.
73. Ifergane G, Buskila D, Simiseshvely N, Zeev K, Cohen H. Prevalence of fibromyalgia syndrome in migraine patients. Cephalgia 2006;26:451-6.
74. Sim J, Adams N. Systematic review of randomized controlled trials of nonpharmaeological interventions for fibromyalgia. Clin J Pain 2002;18:324-36.
75. Rossy LA, Buckelew SP, Dorr N, Hagglund KJ, Thayer JF, McIntosh MJ, et al. A meta-analysis of fibromyalgia treatment interventions. Ann Behav Med 1999;21:180-91.
76. Busch A, Schaehter CL, Peloso PM, Bombardier C. Exercise for treating fibromyalgia syndrome. Cochrane Database Syst Rev 2002;3:CD003786.
77. O'Malley PG, Balden E, Tomkins G, Santoro J, Kroenke K, Jackson JL. Treatment of fibromyalgia with antidepressants: a metaanalysis. J Gen Intern Med 2000;15:659-66.
78. Arnold LM, Keck PE, Welge JA. Antidepressment treatment of fibromyalgia. A meta-analysis and review. Psychosomatics 2000;41:104-13.
79. Sayar K, Aksu G, Ak I, Tosum M. Venlafaxine treatment of fibromyalgia. Ann Pharmacother 2003;37:1561-5.
80. Arnold LM, Lu Y, Crofford L, Wohlreich M, Detke MJ, Iyengar S, et al. A double-blind multicenter trial comparing duloxetin to placebo in the treatment of fibromyalgia with and without major depressive disorder. Arthritis Rheum 2004;50:2974-84.
81. Arnold LM, Goldenberg DL, Stanford SB, Lalonde JK, Sandhu HS, Keck PE Jr, et al. Gabapentin in the treatment of fibromyalgia. A randomized, doble-blind, placebo-controlled, multicentric trial. Arthritis Rheum 2007;56:1336-44.
82. Crofford LJ, Rowbotham MC, Mease P, Russell IJ, Dworkin RH. Corbin AE, et al. Pregabalin for the treatment of fibromyalgia syndrome: results of a randomized, double-blind, placebo-controlled trial. Arthritis Rheum 2005;52:1264-73.
83. Russell IJ, Kamin M, Bennett RM, Schnitzer TJ, Green JA, Katz WA. Efficacy of tramadol in treatment of pain in fibromyalgia. J Clin Rheumatol 2000;6:250-7.
84. Bennett RM, Kamin M, Karim R, Rosenthal N. Tramadol and acetaminophen combination tablets in the treatment of fibromyalgia pain: a double-blind, randomized, placebo controlled study. Am J Med 2003;114:537-45.